J&J Beats Decision Diagnostics Again in Glucose Test Patent Row (1)

Johnson & Johnson did not infringe patents held by Decision Diagnostics’ Pharma Tech Solutions unit when it made its own glucose monitors, according to a precedential decision by the U.S. Court of Appeals for the Federal Circuit.

The Federal Circuit on Nov. 22 upheld a decision by the U.S. District Court for the District of Nevada and granted summary judgment to J&J’s LifeScan, Inc. unit, which makes the OneTouch Ultra system for monitoring blood glucose levels at home.

Lawyers for Pharma Tech argued that LifeScan had infringed two of its patents, which also cover blood glucose monitoring systems that diabetes ...